UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 86 filers reported holding UROGEN PHARMA LTD in Q2 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $891,512 | +40.1% | 63,634 | +3.5% | 0.00% | – |
| Q2 2023 | $636,132 | -25.5% | 61,462 | -35.1% | 0.00% | – |
| Q1 2022 | $854,000 | -5.7% | 94,660 | +1.0% | 0.00% | – |
| Q4 2021 | $906,000 | -45.9% | 93,752 | -6.5% | 0.00% | -100.0% |
| Q3 2021 | $1,674,000 | +13.5% | 100,316 | +3.8% | 0.00% | – |
| Q2 2021 | $1,475,000 | -26.2% | 96,600 | -5.9% | 0.00% | -100.0% |
| Q1 2021 | $2,000,000 | -43.9% | 102,654 | -48.1% | 0.00% | 0.0% |
| Q4 2020 | $3,562,000 | -23.1% | 197,690 | -17.7% | 0.00% | -50.0% |
| Q3 2020 | $4,635,000 | -47.4% | 240,248 | -28.7% | 0.00% | -50.0% |
| Q2 2020 | $8,807,000 | +82.3% | 337,149 | +24.5% | 0.00% | +100.0% |
| Q1 2020 | $4,831,000 | +346.1% | 270,833 | +496.0% | 0.00% | – |
| Q3 2019 | $1,083,000 | -29.6% | 45,444 | +6.1% | 0.00% | -100.0% |
| Q2 2019 | $1,539,000 | – | 42,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,252,285 | $24,156,000 | 7.72% |
| Horton Capital Management, LLC | 375,428 | $7,242,000 | 6.96% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $56,996,000 | 1.27% |
| Phoenix Holdings Ltd. | 901,979 | $16,405,000 | 0.69% |
| SHIKIAR ASSET MANAGEMENT INC | 44,550 | $859,000 | 0.33% |
| Coastal Bridge Advisors, LLC | 37,000 | $714,000 | 0.22% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $14,242,000 | 0.20% |
| Clal Insurance Enterprises Holdings Ltd | 529,388 | $10,212,000 | 0.17% |
| Vivaldi Capital Management LP | 10,000 | $233,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 48,407 | $934,000 | 0.05% |